Omnia SanaPlant Comparison
Aloe Vera vs Meadowsweet
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Aloe Vera and Meadowsweet: they share 9 indicated uses (arthritis / joint pain, back pain, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Aloe Vera | Meadowsweet | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Back pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Headache | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Pain (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Acemannan and other glucomannans are the principal gel polysaccharides, underlying the emollient and wound-healing effects.
Found mainly in the leaf latex (not the inner gel); responsible for the traditional laxative effect and requiring caution with prolonged use.
Minor bioactive enzymes, vitamins (including C and E) and minerals contribute to the antioxidant and skin-conditioning properties of the gel.
Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.
Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.
Contribute to astringency and the characteristic sweet almond-like fragrance.
Pharmacological Actions
Aloe vera and its anthraquinone aloe-emodin show dose-dependent antiproliferative and pro-apoptotic activity against multiple cancer types in vitro and in vivo (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from analgesic action
inferred from vulnerary action
Aloe-emodin, an Aloe vera anthraquinone, induces apoptosis and inhibits growth of gastric, oral squamous, hepatocellular, lung (incl. xenograft) and glioblastoma cancer cells, modulating caspases, Bcl-2/Bax, PI3K/Akt and MEK/ERK signalling (preclinical).
inferred from emollient action
inferred from analgesic action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
Topical use of aloe gel is generally safe for most people. Oral use of aloe latex as a laxative is potentially unsafe with prolonged use due to risk of dehydration, electrolyte imbalance, and potential kidney damage. Aloe latex contains anthraquinone glycosides which may cause abdominal cramping and diarrhea. Not recommended during pregnancy or breastfeeding. May interact with diabetes medications, diuretics, and laxatives. Oral aloe gel at typical doses appears safe short-term but long-term safety is unclear. Allergic reactions possible in sensitive individuals.
Duke (2002) reports clinical evidence (score 2/3) supporting aloe gel's use in psoriasis, constipation (in adults), and as a vulnerary. Gel preparations have been clinically validated for peptic ulcers (excluding stress-induced), radiation burns, and skin ulcers. Dose: 1 tablespoon gel three times daily or 50–200 mg dried juice equivalent per day as a laxative. An important safety distinction is made: the gel (inner leaf mucilage) is AHPA Class 1 (safe), while the inner leaf juice or dried latex is Class 2b due to anthraquinone content and is contraindicated in intestinal inflammation, colitis, Crohn's disease, appendicitis, and during menstruation (Duke, 2002).
Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.
Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).
External Ids
Botanical Description
Succulent, rosette-forming perennial with thick, fleshy, lance-shaped leaves edged with soft, pale teeth, each leaf filled with a clear, slippery, mucilaginous gel beneath a tougher green rind. In favourable conditions it produces a tall flowering spike bearing tubular yellow (sometimes orange) flowers.[1]
Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]
Habitat
Believed native to the Arabian Peninsula, and now cultivated and naturalised throughout arid and semi-arid tropical and subtropical regions worldwide as a garden, medicinal and commercial crop.[1]
Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]
Harvesting
Outer, mature leaves are cut close to the base as needed; the clear inner gel (mucilage) is separated from the outer rind and from the bitter yellow latex (aloin-containing exudate) just under the rind, since the gel and the latex have different uses and safety profiles.[1]
The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]
Traditional Uses
Aloe vera has an ancient reputation, recorded from ancient Egypt onward, as a topical remedy for burns, wounds and skin inflammation (the 'burn plant' / 'first aid plant'), and the bitter leaf latex has been used traditionally as a stimulant laxative. It remains one of the most widely used topical botanicals for skin care and minor wound healing.[1]
Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]
Preparations
Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.
Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.
Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.
Dosage
The WHO monograph on Aloe Vera Gel specifies fresh gel, or preparations containing 10-70% fresh gel, applied to the affected skin area. Educational reference only, not a prescription.
The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Sanchez, M., Gonzalez-Burgos, E., Iglesias, I. and Gomez-Serranillos, M.P (2020) 'Pharmacological update properties of Aloe vera and its major active constituents', Molecules, 25(6), pp. 1324. doi:10.3390/molecules25061324 Meta-analysis / review
https://doi.org/10.3390/molecules25061324 - Kaur, S. and Bains, K (2023) 'Aloe barbadensis Miller (Aloe vera)', International Journal for Vitamin and Nutrition Research, 94(3-4), pp. 308-321. doi:10.1024/0300-9831/a000797 Meta-analysis / review
https://doi.org/10.1024/0300-9831/a000797 - Catalano, A., Ceramella, J., Iacopetta, D., Marra, M., Conforti, F., Lupi, F.R., Gabriele, D., Borges, F. and Sinicropi, M.S (2024) 'Aloe vera - an extensive review focused on recent studies', Foods, 13(13), pp. 2155. doi:10.3390/foods13132155 Meta-analysis / review
https://doi.org/10.3390/foods13132155 - Surjushe, A., Vasani, R. and Saple, D.G (2008) 'Aloe vera: a short review', Indian Journal of Dermatology, 53(4), pp. 163-166. doi:10.4103/0019-5154.44785 Meta-analysis / review
https://doi.org/10.4103/0019-5154.44785 - Liang, J., Cui, L., Li, J., Guan, S., Zhang, K. and Li, J (2020) 'Aloe vera: a medicinal plant used in skin wound healing', Tissue Engineering Part B: Reviews, 27(5), pp. 455-474. doi:10.1089/ten.TEB.2020.0236 Meta-analysis / review
https://doi.org/10.1089/ten.TEB.2020.0236 - Guo, X. and Mei, N (2016) 'Aloe vera: a review of toxicity and adverse clinical effects', Journal of Environmental Science and Health Part C, 34(2), pp. 77-96. doi:10.1080/10590501.2016.1166826 Meta-analysis / review
https://doi.org/10.1080/10590501.2016.1166826 - Boyapati, R., Peeta, J., Dhulipalla, R., Kolaparthy, L., Adurty, C. and Cheruvu, R.N.S (2024) 'Comparative evaluation of the efficacy of probiotic, Aloe vera, povidine-iodine, and chlorhexidine mouthwashes in the treatment of gingival inflammation: a randomized controlled trial', Dental and Medical Problems, 61(2), pp. 181-190. doi:10.17219/dmp/156425 Randomized trial
https://doi.org/10.17219/dmp/156425 - Hekmatpou, D., Mehrabi, F., Rahzani, K. and Aminiyan, A (2019) 'The effect of Aloe vera clinical trials on prevention and healing of skin wound: a systematic review', Iranian Journal of Medical Sciences, 44(1), pp. 1-9. Meta-analysis / review
https://scholar.google.com/scholar?q=The%20effect%20of%20Aloe%20vera%20clinical%20trials%20on%20prevention%20and%20healing%20of%20skin%20wound%3A%20a%20systematic%20review - Gao, Y., Kuok, K.I., Jin, Y. and Wang, R (2018) 'Biomedical applications of Aloe vera', Critical Reviews in Food Science and Nutrition, 59(sup1), pp. S244-S256. doi:10.1080/10408398.2018.1496320 Meta-analysis / review
https://doi.org/10.1080/10408398.2018.1496320 - Feily, A. and Namazi, M.R (2009) 'Aloe vera in dermatology: a brief review', Giornale Italiano di Dermatologia e Venereologia, 144(1), pp. 85-91. Meta-analysis / review
https://scholar.google.com/scholar?q=Aloe%20vera%20in%20dermatology%3A%20a%20brief%20review - Sierra-Garcia, G.D., Castro-Rios, R., Gonzalez-Horta, A., Lara-Arias, J. and Chavez-Montes, A (2014) 'Acemannan, an extracted polysaccharide from Aloe vera: a literature review', Natural Product Communications, 9(8), pp. 1217-1221. doi:10.1177/1934578x1400900836 Meta-analysis / review
https://doi.org/10.1177/1934578x1400900836 - World Health Organization (1999) 'Aloe Vera Gel'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Femenia A, Sánchez ES, Simal S, Rosselló C. Compositional features of polysaccharides from Aloe vera (1999) ';39(2):109-117', 39(2). Traditional / reference
https://scholar.google.com/scholar?q=%3B39%282%29%3A109-117. - Catalano A, Iacopetta D, Ceramella J, et al. Aloe vera - An extensive review focused on recent studies. Foods. 2024;13 (2024) ';13(13):2155', 13(13). Traditional / reference
https://scholar.google.com/scholar?q=%3B13%2813%29%3A2155. - Hekmatpou D, Mehrabi F, Rahzani K, Aminiyan A. The effect of Aloe vera clinical trials on prevention and healing of skin wound: A systematic review. Iran J Med Sci. 2019;44 (2019) ';44(1):1-9', 44(1). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6330525/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC6330525/ - National Center for Complementary and Integrative Health. Aloe vera. NIH. 2020. https://www.nccih.nih.gov/health/aloe-vera (2020) 'https://www.nccih.nih.gov/health/aloe-vera'. Available at: https://www.nccih.nih.gov/health/aloe-vera Traditional / reference
https://www.nccih.nih.gov/health/aloe-vera - Sahu PK, Giri DD, Singh R, et al. Therapeutic and medicinal uses of Aloe vera: A review. Pharmacol Pharm. 2013;4:599-610 (2013) ';4:599-610'. Traditional / reference
https://scholar.google.com/scholar?q=%3B4%3A599-610. - Sánchez M, González-Burgos E, Iglesias I, Gómez-Serranillos MP. Pharmacological update properties of Aloe vera and its major active constituents. Molecules. 2020;25 (2020) ';25(6):1324', 25(6). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7144722/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC7144722/ - Surjushe A, Vasani R, Saple DG. Aloe vera: A short review. Indian J Dermatol. 2008;53 (2008) ';53(4):163-166', 53(4). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC2763764/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC2763764/ - Ulbricht C, Armstrong J, Basch E, et al. An evidence-based systematic review of Aloe vera by the Natural Standard Research Collaboration. J Herb Pharmacother. 2008;7 (2008) ';7(3-4):279-323'. Available at: https://www.ncbi.nlm.nih.gov/books/NBK92765/ Traditional / reference
https://www.ncbi.nlm.nih.gov/books/NBK92765/ - Haroon, N. and Amjad, A. and Maaz, M. and Noman, A.M. and Anees, N. and Muhammad, Z. and Shah, M. and Al Abdulmonem, W (2026) 'Phytochemistry, Bioavailability, and Molecular Mechanisms Underlying Multitarget Anticancer Activity of Aloe vera', Nutrients, 18(12), pp. 2034. doi:10.3390/nu18122034 Preclinical
https://doi.org/10.3390/nu18122034 - Chen, S.-H. and Lin, K.-Y. and Chang, C.-C. and Fang, C.-L. and Lin, C.-P (2007) 'Aloe-emodin-induced apoptosis in human gastric carcinoma cells', Food and Chemical Toxicology, 45(11), pp. 2296-2303. doi:10.1016/j.fct.2007.06.005 Preclinical
https://doi.org/10.1016/j.fct.2007.06.005 - Li, Q. and Wen, J. and Yu, K. and Shu, Y. and He, W. and Chu, H. and Zhang, B. and Ge, C (2018) 'Aloe-emodin induces apoptosis in human oral squamous cell carcinoma SCC15 cells', BMC Complementary and Alternative Medicine, 18(1), pp. 296. doi:10.1186/s12906-018-2353-z Preclinical
https://doi.org/10.1186/s12906-018-2353-z - Arcella, A. and Sanchez, M (2021) 'Natural substances to potentiate canonical glioblastoma chemotherapy', Journal of Chemotherapy, 33(5), pp. 276-287. doi:10.1080/1120009X.2021.1873633 Preclinical
https://doi.org/10.1080/1120009X.2021.1873633 - Zhu, M. and He, Q. and Wang, Y. and Duan, L. and Rong, K. and Wu, Y. and Ding, Y. and Mi, Y. and Ge, X. and Yang, X. and Yu, Y (2023) 'Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments', Frontiers in Pharmacology, 14, pp. 1238841. doi:10.3389/fphar.2023.1238841 Preclinical
https://doi.org/10.3389/fphar.2023.1238841 - Kim, H.J. and Choi, J.W. and Ree, J. and Lim, J.S. and Lee, J. and Kim, J.I. and Thapa, S.B. and Sohng, J.K. and Park, Y.I (2022) 'Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways', Life Sciences, 300, pp. 120495. doi:10.1016/j.lfs.2022.120495 Preclinical
https://doi.org/10.1016/j.lfs.2022.120495 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Suksomboon, N., Poolsup, N. and Punthanitisarn, S (2016) 'Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis', Journal of Clinical Pharmacy and Therapeutics, 41(2), pp. 180-188. doi:10.1111/jcpt.12382 Meta-analysis / review
https://doi.org/10.1111/jcpt.12382 - Suksomboon, N., Poolsup, N. and Punthanitisarn, S (2016) 'Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis', Journal of Clinical Pharmacy and Therapeutics, 41(2), pp. 180-188. doi:10.1111/jcpt.12382 Meta-analysis / review
https://doi.org/10.1111/jcpt.12382 - Gardening Know How 'Aloe Vs. Agave Plants: What's The Difference Between Aloe And Agave'. Available at: https://www.gardeningknowhow.com/ornamental/cacti-succulents/scgen/how-to-tell-agave-and-aloe-apart.htm Traditional / reference
https://www.gardeningknowhow.com/ornamental/cacti-succulents/scgen/how-to-tell-agave-and-aloe-apart.htm - Ricks, M.R. and Vogel, P.S. and Elston, D.M. and Hivnor, C (1999) 'Purpuric agave dermatitis', Journal of the American Academy of Dermatology, 40(2 Pt 2), pp. 356-8. doi:10.1016/s0190-9622(99)70485-8 Clinical study
https://doi.org/10.1016/s0190-9622(99)70485-8 - Genillier-Foin, N. and Avenel-Audran, M (2007) 'Purpuric contact dermatitis from Agave americana', Annales de Dermatologie et de Venereologie, 134(5 Pt 1), pp. 477-8. doi:10.1016/s0151-9638(07)89218-0 Clinical study
https://doi.org/10.1016/s0151-9638(07)89218-0
- Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
https://doi.org/10.1016/j.jep.2017.11.013 - Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
https://doi.org/10.3390/antiox13101200 - Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
https://doi.org/10.3390/pharmaceutics15041291 - Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
https://doi.org/10.1016/j.jep.2016.10.015 - Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
https://doi.org/10.1016/j.jep.2016.10.024 - Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
https://doi.org/10.1016/j.fct.2016.11.018 - Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
https://doi.org/10.31083/j.jin2004089 - Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
https://doi.org/10.1016/j.jep.2015.08.025 - Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
https://doi.org/10.3390/molecules28176349 - Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
https://doi.org/10.1055/s-2006-962390 - Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
https://doi.org/10.1055/a-1647-2866 - Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
https://doi.org/10.1080/09553002.2016.1257834 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf - Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook - Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.